Indomethacin/Cu/LDPE porous composite for medicated copper intrauterine devices with controlled release performances
Source abstract
Abstract
Abstract A novel functional material, indomethacin/copper/low density polyethylene (IDM/Cu/LDPE) porous composite, has been developed for medicated copper intrauterine devices (Cu-IUDs). The aim of this study was to report its preparation, structure and release performances. Samples of the IDM/Cu/LDPE porous composite were prepared by a combined technique involved in injection molding, particulate leaching, IDM solution incubating, and solvent vacuum drawing. Results of structure characterizations of these prepared samples show that the IDM/Cu/LDPE porous composite is obtained successfully and it is only a simple hybrid of IDM, copper particles and LDPE, and both the IDM and the copper particles are generally distributed homogeneously in its porous LDPE matrix. Results of IDM-loaded and release properties characterizations of these prepared samples show that the amount of loaded-IDM increases with the increasing of introduced porosity, and the release rates of both IDM and cupric ions increase with the increasing of porosity for these prepared samples with the same 25 wt.% of copper particles. It indicates that this novel porous composite not only can control its release of IDM, but also can control its release of cupric ions, its release properties can be regulated easily by controlling its amount of introduced porosity.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. The ESHRE Capri Workshop Group. Intrauterine devices and intrauterine systems. Hum Reprod Update 2008; 14:197–208.10.1093/humupd/dmn003 ↗
2. Characterization of copper in uterine fluids of patients who use the copper T-380A intrauterine device10.1016/S0009-8981(03)00124-4 ↗
3. Copper corrosion-simulated uterine solutions10.1016/S0010-7824(00)00124-4 ↗
4. The ESHRE Capri Workshop Group. Endometrial bleeding. Hum Reprod Update 2007; 13:421–31.10.1093/humupd/dmm001 ↗
5. Formation of copper oxychloride and reactive oxygen species as causes of uterine injury during copper oxidation of Cu-IUD10.1016/S0010-7824(00)00085-8 ↗
6. Does over-exposure to copper ions released from metallic copper induce cytotoxic and genotoxic effects on mammalian cells?10.1016/j.contraception.2009.12.003 ↗
7. Preparation, structure and thermal stability of Cu/LDPE nanocomposites10.1016/j.matchemphys.2005.05.010 ↗
8. Corrosion behavior of copper/LDPE nanocomposites in simulated uterine solution10.1016/j.biomaterials.2004.08.003 ↗
9. Comparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUD10.1016/j.contraception.2008.05.008 ↗
10. Effect of implanted Cu/low-density polyethylene nanocomposite on the mouse the morphology of endometrium in the mouse10.1016/j.fertnstert.2006.11.122 ↗
11. A preliminary morphometric study on the endometrium from patients treated with indomethacin-releasing copper intrauterine device10.1093/humrep/12.7.1563 ↗
12. Cochrane systematic reviews of IUD trials: lessons learned10.1016/j.contraception.2006.12.004 ↗
13. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs10.1016/j.amjmed.2008.01.045 ↗
14. An oral delivery system for indomethicin engineered from cationic lipid emulsions and silica nanoparticles10.1016/j.jconrel.2010.01.008 ↗
15. Silica and dysprosia aerogels as drug carriers for indomethacin and paracetamol
16. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant)10.1093/oxfordjournals.humrep.a019416 ↗
17. A 10-year experience in removing Chinese intrauterine devices10.1016/j.ijgo.2009.12.018 ↗
18. Indomethacin release behavior and surface characteristics of the novel Cu/Indomethacin/LDPE nanocomposite for intrauterine device10.1016/j.colsurfb.2008.11.027 ↗
19. An approach to give prospective life-span of the copper/low-density-polyethylene nanocomposite intrauterine device10.1007/s10856-011-4347-y ↗
20. 2,5-Di-tert-butyl-1,4-hydroquinone enhances cell transformation accompanied by an increase in intracellular free calcium ion concentration10.1016/S0304-3835(01)00531-6 ↗
21. Cupric ion release controlled by copper/low-density polyethylene nanocomposite in simulated uterine solution10.1002/jbm.b.30587 ↗
22. Morphological evaluation of the γ-polymorph of indomethacin10.1016/S0022-0248(01)01924-8 ↗
23. Solid-state 13C NMR study of indomethacin polymorphism10.1016/j.ijpharm.2006.03.029 ↗
24. Nanoparticles formed from PNIPAM-g-PEO copolymers in the presence of indomethacin10.1016/j.ijpharm.2009.09.034 ↗
25. Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized10.1016/S0010-8545(02)00086-3 ↗